Direct Dial: 573-882-6753
Erika Lietzan is a Senior Scholar at CPIP. She is an Associate Professor of Law at the University of Missouri–Columbia, where she teaches and writes in the areas of drug and device regulation, intellectual property, and administrative law. Her primary research focus lies at the intersection of intellectual property law and FDA regulation of medical products. Her scholarship has focused on the new drug research and development paradigm and its impact on incentives to innovate, innovation and competition in the marketplace for biological medicines, the incentive for generic drug applicants to challenge innovator patents, data exclusivity for drug and biological medicine innovators, and mandatory public disclosure of clinical data in drug applications, among other issues. Her articles can be downloaded here.
Professor Lietzan brings to her scholarship and teaching eighteen years of private practice experience, eight of them as a partner at Covington & Burling in Washington, DC. She received her law degree from Duke University, a master’s degree in history from UCLA, and bachelor’s degree in history from the University of North Carolina.